VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is pleased to announce the appointment… Read More
The network’s second phase will focus on translating research findings into better kidney health care for Canadians The Can-SOLVE CKD Network is Canada’s largest-ever kidney research initiative. Since 2016, this… Read More
Are you looking to scale up your innovative digital health or medical technology company and gain a foothold in Asia? If so, the Canadian Trade Commissioner Service (TCS) invites you to… Read More
VANCOUVER, BC — Ondine Biomedical Inc. (LON: OBI), has recruited the final patient to its nasal photodisinfection exploratory Phase 2 trial. The trial is evaluating how effectively Ondine’s nasal photodisinfection… Read More
Approximately 6,000 participants 5 years of age and older will be enrolled in Lyme disease-endemic regions in Europe and the U.S. NEW YORK & SAINT-HERBLAIN, FRANCE– Pfizer Inc. (NYSE: PFE) and Valneva… Read More
